US2021186328A1PendingUtilityA1

Integrated medicament delivery device for use with continuous analyte sensor

Assignee: DEXCOM INCPriority: Feb 26, 2004Filed: Mar 9, 2021Published: Jun 24, 2021
Est. expiryFeb 26, 2024(expired)· nominal 20-yr term from priority
A61M 2205/3592A61M 2209/086A61M 2205/502A61B 2560/0443A61M 2230/201A61B 5/14532A61M 2205/581A61M 5/1723A61M 5/24A61B 5/14546A61B 2560/0431A61B 2560/04A61M 2205/582A61M 5/31525G16H 40/67A61M 2205/3561G16H 20/17A61B 5/0002A61B 5/1486A61M 2205/583A61B 2560/0406A61M 2205/3569A61B 5/4839A61M 5/003A61M 2205/50
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An integrated system for monitoring and treating diabetes, the system comprising:
 a medicament injection pen configured and arranged for injecting an amount of a medicament into a host; and   an integrated receiver configured and arranged to receive sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration of the host in vivo, wherein the integrated receiver comprises electronics configured and arranged to process the sensor data.   
     
     
         2 . The integrated system of  claim 1 , wherein the electronics are further configured to calculate at least one of time of medicament therapy and amount of medicament therapy. 
     
     
         3 . The integrated system of  claim 1 , wherein the integrated receiver comprises a housing, wherein the medicament injection pen is integrally formed with the housing. 
     
     
         4 . The integrated system of  claim 1 , wherein the integrated receiver comprises a housing, and wherein the medicament injection pen is detachably connectable to the housing. 
     
     
         5 . The integrated system of  claim 4 , wherein communication between the medicament injection pen and the receiver is initiated based at least in part on detachable connection of the medicament injection pen and the housing. 
     
     
         6 . The integrated system of  claim 1 , further comprising a user interface configured and arranged for at least one of input of host information, output of sensor data, and medicament therapy. 
     
     
         7 . The integrated system of  claim 6 , wherein the user interface is further configured to display a graphical representation of at least one of sensor data and medicament delivery data, wherein a solid line represents at least one of a target glucose concentration and a range. 
     
     
         8 . The integrated system of  claim 1 , wherein the integrated electronics are configured and arranged to require validation prior to injecting an amount of medicament into the host. 
     
     
         9 . The integrated system of  claim 1 , wherein the receiver is configured to communicate in at least one of wiredly with a single-point glucose monitor and wirelessly with a single-point glucose monitor. 
     
     
         10 . The integrated system of  claim 1 , wherein the medicament injection pen comprises a motor. 
     
     
         11 . The integrated system of  claim 10 , wherein the motor is configured to set the amount of medicament. 
     
     
         12 . The integrated system of  claim 10 , wherein the motor is configured to control a rate of medicament injection into a host. 
     
     
         13 . The integrated system of  claim 10 , wherein the receiver is configured to remotely control the motor. 
     
     
         14 . The integrated system of  claim 1 , wherein the medicament injection pen and the receiver each comprise mutually engaging electrical contacts, and wherein the mutually engaging electrical contacts are configured to allow communication between the medicament injection pen and the receiver. 
     
     
         15 . The integrated system of  claim 14 , wherein the system is configured to initiate communication between the medicament injection pen and the receiver in response to engagement of the electrical contacts. 
     
     
         16 . The integrated system of  claim 14 , wherein the system is configured to communicate medicament delivery data between the medicament injection pen and the receiver in response to engagement of the electrical contacts. 
     
     
         17 . The integrated system of  claim 1 , further comprising a receptacle configured and arranged to receive at least one of parts associated with the medicament injection pen and accessories associated with the medicament injection pen. 
     
     
         18 . The integrated system of  claim 1 , wherein at least one of the parts associated with the medicament injection pen and accessories associated with the medicament injection pen comprise a medicament cartridge. 
     
     
         19 . The integrated system of  claim 1 , further comprising a medicament injection pen kit, wherein the medicament injection pen kit is configured to receive the medicament injection pen, and wherein the medicament injection pen kit comprises a housing comprising a user interface, and wherein the integrated receiver is located within the housing and operably connected to the user interface. 
     
     
         20 . An integrated system for monitoring and treating diabetes, the system comprising:
 a receiver configured and arranged to receive sensor data from an operably connected continuous glucose sensor, wherein the continuous glucose sensor is configured and arranged to generate sensor data associated with a glucose concentration of a host;   integrated electronics configured to process the sensor data and to generate a medicament therapy; and   a medicament injection pen configured to inject an amount of medicament into the host.

Join the waitlist — get patent alerts

Track US2021186328A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.